(Q41062792)

26 September 2017

Relations of hyaluronidase to salicylates and rheumatic fever (English)

1 reference

26 September 2017

0 references

JAWORSKI AA

1

1 reference

26 September 2017

FARLEY JE Jr

series ordinal

2

1 reference

26 September 2017

BARRET J

series ordinal

3

1 reference

26 September 2017

JAWORSKI RA

series ordinal

4

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 November 1950

1 reference

The Journal of Pediatrics

26 September 2017

1 reference

26 September 2017

37

1 reference

26 September 2017

5

1 reference

26 September 2017

697-708

1 reference

The role of allergy in the pathogenesis of rheumatic fever

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

Hyaluronidase Inhibition by Sodium Salicylate in Rheumatic Fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

The biological significance of hyaluronic acid and hyaluronidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

THE EFFECT OF EXTRACTS OF CERTAIN ORGANS FROM NORMAL AND IMMUNIZED ANIMALS ON THE INFECTING POWER OF VACCINE VIRUS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

Metachromasia in mammalian tissues and its relationship to mucopolysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

Studies on diffusing factors: 3. A new biological assay of diffusing factor in guinea-pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

THE HYDROLYSIS OF HYALURONIC ACID BY BACTERIAL ENZYMES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

Action of sodium salicylate on hyaluronidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

THE EQUILIBRIA BETWEEN NATIVE AND DENATURED HEMOGLOBIN IN SALICYLATE SOLUTIONS AND THE THEORETICAL CONSEQUENCES OF THE EQUILIBRIUM BETWEEN NATIVE AND DENATURED PROTEIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

Failure of Sodium Salicylate to Inhibit Hyaluronidase in Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

The inhibition of hyaluronidase by sodium salicylate and its possible metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

Hyaluronidase inhibitors in body fluids in normal and disease states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

On the occurrence in human serum of an inhibitory substance to hyaluronidase produced by a strain of hemolytic streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

ANTIHYALURONIDASE STUDIES OF SERA FROM PATIENTS WITH RHEUMATIC FEVER, STREPTOCOCCAL INFECTIONS, AND MISCELLANEOUS NON-STREPTOCOCCAL DISEASES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

Mucolytic enzyme systems; nonspecific hyaluronidase inhibitor in rheumatic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

STUDIES ON SPREADING FACTORS : I. THE IMPORTANCE OF MECHANICAL FACTORS IN HYALURONIDASE ACTION IN SKIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

Therapeutic measures in rheumatic fever; a comparative study of 150 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

Studies on the relation of pituitary-adrenal function to rheumatic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

Influence of hyaluronidase and steroids on permeability of synovial membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2850%2980066-5

10.1016/S0022-3476(50)80066-5

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference